Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00795184 · ClinicalTrials.gov registry record · NA

Detection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal Endomicroscopy

A NA study, sponsored by Mauna Kea Technologies.

Completed
Registry status
NA
Development phase
122
Enrollment target

NCT00795184 is a NA study that has completed, run by Mauna Kea Technologies. The registered enrollment target is 122 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00795184, a NA study, has completed, sponsored by Mauna Kea Technologies.

COMPLETED
Registry status
NA
Development phase
122 participants
Enrollment target

Study Summary

This study will collect data from patients routinely undergoing a endoscopic surveillance and Cellvizio endomicroscopy procedure due to confirmed Barrett's esophagus. The objective is to determine if endomicroscopy images collected using the marketed Cellvizio device may help endoscopists more accurately diagnose, in conjunction with traditional tissue sampling techniques, whether a suspected lesion is malignant or benign.

Interventions

  • DEVICE Imaging procedures (NBI)
  • DEVICE HDWLE
  • DEVICE pCLE

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2008-11
Est. Completion 2010-02
Phase NA

Sponsor

Mauna Kea Technologies

6 total trials

What the Registry Record Tells You About NCT00795184

The ClinicalTrials.gov registry entry for NCT00795184 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mauna Kea Technologies, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Imaging procedures (NBI) is the first listed.

NCT00795184 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00795184 about?

NCT00795184 is a clinical study titled "Detection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal Endomicroscopy". This study will collect data from patients routinely undergoing a endoscopic surveillance and Cellvizio endomicroscopy procedure due to confirmed Barrett's esophagus. The objective is to determine if endomicroscopy images collected using the marketed Cellvizio device may help endoscopists more accur...

What is the current status of trial NCT00795184?

This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2008-11. Estimated completion is 2010-02.

What interventions are being tested in trial NCT00795184?

The interventions under investigation include: Imaging procedures (NBI) (DEVICE), HDWLE (DEVICE), pCLE (DEVICE).

Who is sponsoring clinical trial NCT00795184?

This trial is sponsored by Mauna Kea Technologies, which has 6 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.